ZIVO Bioscience (ZIVO) Insider Trading & Ownership $4.06 0.00 (0.00%) As of 05/19/2026 Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock ZIVO Bioscience (NASDAQ:ZIVO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage48.90%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$199.60KNumber OfInsiders Selling(Last 3 Years)0 Get ZIVO Insider Trade Alerts Want to know when executives and insiders are buying or selling ZIVO Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ZIVO Insider Buying and Selling by Quarter ZIVO Bioscience Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/2/2023Mark E StromeMajor ShareholderBuy40,000$4.99$199,600.00 (Data available from 1/1/2013 forward) ZIVO Insider Trading Activity - Frequently Asked Questions Who is on ZIVO Bioscience's Insider Roster? The list of insiders at ZIVO Bioscience includes Mark E Strome. Learn more on insiders at ZIVO. What percentage of ZIVO Bioscience stock is owned by insiders? 48.90% of ZIVO Bioscience stock is owned by insiders. Learn more on ZIVO's insider holdings. ZIVO Bioscience Active InsidersNola E. MastersonDirectorChristopher D MaggioreDirectorJohn Bernard Payne (Age 78)Director More Insider Trading Tools from MarketBeat Related Companies LIXT Insider Selling KALA Insider Selling IBIO Insider Selling SCLX Insider Selling INKT Insider Selling TIL Insider Selling KZR Insider Selling MGX Insider Selling ESLA Insider Selling TLPH Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Latest Articles 3 Dividend Stocks With Insiders Buying in 2026Insider Buying Says Upstart Isn’t Down for the CountInsider Trades: Okta and Abbott See Buys, Micron Insiders SellMarketBeat Week in Review – 05/04 - 05/08BlackBerry Rewrites Its Own Operating System This page (NASDAQ:ZIVO) was last updated on 5/20/2026 by MarketBeat.com Staff. From Our PartnersYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredFed story no one is tellingJ.P. Morgan's Private Bank quietly advised 333 billionaire families to move 60% of their portfolios into alter...TradeSmith | SponsoredOne page of the SpaceX S-1 will move this stock overnightWhen SpaceX files its S-1 in June, the SEC will require full disclosure of operating expenses - including powe...Behind the Markets | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredThis same-day trade is getting a lot of attentionZero-days-to-expiration trades happen every single day - and most traders either ignore them or use them wrong...Base Camp Trading | SponsoredThe sell discipline that changed my mind after 30 yearsPorter Stansberry spent 30 years ignoring outside investment systems - until he met Emmet Savage in Dublin. Sa...Porter & Company | SponsoredMemorial Day Event: Save 79% on Weiss Ratings Plus!Elon Musk calls it 'mind-blowing.' Fox News calls the scramble for it 'the new arms race.' Chris Graebe, Chief...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZIVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZIVO Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
